At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 50 enrolled

Drug / intervention

0.1% Ropivacaine +1 moredrug

Likely dose

0.1% Ropivacaine 12mLfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00912873

NCT00912873Phase 4Completed

Compare CT.gov

Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks

University of California, San Diego·interventional·Posted Jun 3, 2009·Updated Mar 11, 2021

In Brief

A Phase 4 clinical trial evaluating 0.1% Ropivacaine and 0.4% Ropivacaine for Hip Arthroplasty and Hip Pain. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This is a research study to determine if the concentration of local anesthetic through a catheter next to the nerves that go to the hip that is undergoing surgery, affects muscle strength and sense of touch experienced after surgery. This study is looking at the varying concentrations of local anesthetic placed through the catheter.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHip Arthroplasty, Hip Pain

CountriesUnited States

Collaborators--

Timeline

Phase 4CompletedFinished

20082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartMay 2008

Primary CompletionJun 2009

First PostedJun 2009

TodayJul 2026

First PostedJun 3, 2009

Enrollment StartMay 1, 2008

Primary CompletionJun 1, 2009

TodayJul 2, 2026

Enrollment to primary: 1.1 yearsPosted 17.1 years ago

Interventions

0.1% Ropivacainedrug

Ropivacaine 0.1% will be administered via the perineural catheter as follows: Basal Rate (12mL/h); Basal Dose (12 mg/h); Bolus Volume (4 mL); Bolus Dose (4 mg); Lockout Duration (30 min); Maximum Dose (20 mg/h)

0.4% Ropivacainedrug

Ropivacaine 0.1% will be administered via the perineural catheter as follows: Basal Rate (3 mL/h); Basal Dose (12 mg/h); Bolus Volume (1 mL); Bolus Dose (4 mg); Lockout Duration (30 min); Maximum Dose (20 mg/h)